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Abstract 
Objectives: Efforts to enhance the reporting of clinical trials have intensified in recent years 
with automated strategies and editorial involvement showing promise in improving 
compliance with accepted guidelines. This study aimed to evaluate the effectiveness of a 
concerted approach to adherence to CONSORT (CONsolidated Standards Of Reporting Trials) 
guidelines in a dental journal.  
Materials and Methods: Following the publication of an exemplar clinical trial on the 
American Journal of Orthodontics and Dentofacial Orthopedics (AJO-DO) website and 
related changes to the author guidelines, trial submissions were required to follow a 
standard format incorporating subheadings mirroring the CONSORT guidelines. Compliance 
with CONSORT was assessed in initial submissions over a 30-month period. Reporting was 
compared to submissions of randomized controlled trials (RCTs) which did not include 
subheadings over the same period. 
Results: Seventy-one RCTs were submitted to the AJO-DO from January 2014 to June 2016, 
49 with subheadings and 22 without. Most CONSORT items (e.g. random sequence 
generation, allocation concealment and blinding) were more frequently adequately reported 
when RCTs were submitted with inclusion of subheadings. Overall, reporting quality of the 
submitted RCTs was 15.2% higher with use of the subheadings format (95%CI: 10.5, 20.0; 
p<0.001) with a mean overall score of 87.3%. 
Conclusion: Enhanced compliance of submitted RCTs was found with use of a bespoke 
approach to trial presentation utilizing CONSORT item subheadings. The improvement in 
initial submissions is particularly encouraging as this arose without input either from peer 
reviewers or journal editors. This simple approach may have wider applicability.  
Keywords: reporting guidelines; orthodontics; dentistry; adherence; RCTs; AJODO; CONSORT 
Introduction  
The importance of transparent reporting of research studies not least randomized controlled 
trials (RCTs) is well-established. The CONsolidated Standards of Reporting Trials (CONSORT) 
guidelines were directed at informing the reporting of RCTs[1] . CONSORT has been 
endorsed by most leading journals with authors encouraged to adhere to recommendations 
within their submissions. Moreover, numerous modifications to CONSORT have been made 
to account for variations in trial design, setting and outcomes[2–4].  
While CONSORT has become established and accepted, a plethora of research from 
biomedical specialties suggests that the published literature remains beset by poor 
reporting[5–8]. In particular, reporting of trials published in the medical and dental literature 
have been suboptimal and, while some benefit has accrued from  endorsement of reporting 
guidelines [5], expose the ineffectiveness of existing passive approaches to CONSORT 
compliance with more innovative or involved systems required to optimise reporting. This 
has spawned a range of initiatives including more involved editorial processes and 
automated means of improving reporting[9], with increased editorial involvement leading to 
considerable improvement in reporting of clinical trials within in a dental specialty 
journal[9].  
The American Journal of Orthodontics and Dentofacial Orthopedics (AJO-DO) has been 
proactive in promoting reporting in accordance with CONSORT with the approach to 
enhancing CONSORT compliance evolving in recent years. Initially (from June 2011), a 
systematic process involving the editor-in-chief (EiC), an associate editor (AE) and RCT 
authors was adopted whereby initial RCT submissions were first assessed by the AE to 
ensure all CONSORT items were reported completely following transfer from the EiC. The AE 
replied to the authors listing unreported items and highlighting ways to address 
incompletely reported items prior to resubmission. Resubmitted manuscripts were again 
scrutinized by the AE for CONSORT adherence and then sent for standard peer review. This 
initiative led to near complete reporting of most CONSORT items in published articles but 
did require significant input from the editorial team[9]. Similar approaches may not, 
however, be applicable to other journals in view of the increased onus on editorial, time, 
input and expertise. In order to improve reporting at the submission level, the approach 
changed in January, 2014 with the adoption of a publication template incorporating 20 
subheadings corresponding to the 27 CONSORT items. A model clinical trial report and a 
specialty specific CONSORT explanation paper providing the rationale for reporting of 
individual items were also published[10,11]. 
As such, the present study examines the impact the use of subheadings based on CONSORT 
items on the reporting of clinical trials submitted to a dental specialty journal. We also 
aimed to highlight areas where deficient reporting within initial submissions exists. 
Methods 
The completeness of reporting was compared between RCTs submitted to AJO-DO with or 
without subheadings based on the CONSORT items. Both cohorts included all RCTs 
submitted for publication between the January 2014 and June 2016. The sample was divided 
based on whether the submission was presented in-line with suggested subheadings (Table 
1) [11]. No inclusion restrictions in terms of trial design were applied. Two experienced 
researchers were involved in the data extraction process. Data from 10 papers were 
extracted independently and consensus was reached for training and calibration purposes. 
Consequently, the first author extracted all data from the remaining papers.  
RCT reports were assessed based on whether they reported all items completely. Items were 
rated as either not reported, incompletely reported, or completely reported. Furthermore, a 
scoring system was used based on a modified and expanded CONSORT item list for the 
evaluation of quality of reporting, in line with a previous analysis[12]. Scores for each item 
ranged from 1 to 3 with 1 indicating no description, a score of 2 representing inadequate 
description, and 3 indicative of adequate description. The scores for all 37 items were 
combined and a percentage score was derived. Non-applicable items did not receive any 
score. For example, the maximum for a trial with adequate description for all items was 111 
corresponding to 100%. On the same basis, an RCT with 30 applicable items could receive a 
maximum score of 90, also equivalent to 100%. Subsequently, each item was converted to a 
binary variable to enable comparison of RCTs submitted with subheadings to those without 
subheadings for each reporting item using a dichotomous measure (i.e. adequate reporting 
vs no reporting/inadequate reporting.    
Descriptive statistics and frequency distributions of compliance with CONSORT items were 
reported for both cohorts. A t-test was conducted to identify differences in reporting scores 
between submissions with and without subheadings. All analyses were carried out using 
Stata 14.1 (Stata Corp, College Station, TX, USA), with the level of statistical significance set 
at p=0.05. 
Results 
Over the 30-month period (January 2014 to June 2016), a total of 71 RCTs were submitted to 
the AJO-DO and assessed for completeness of reporting. Forty- nine of these initial 
submissions incorporated subheadings, while 22 did not. The majority of submission were 
from authors in Asia/Other regions (n= 41; 58%), with 23% (n= 16) from the Americas and 
20% (n= 14) from Europe. 
A number of pivotal items were more frequently adequately reported when RCTs were 
submitted with inclusion of subheadings (Table 2). In particular, sample size (subheadings: 
25/49, 51%; no subheadings: 6/22, 27%), random sequence generation (subheadings: 33/49, 
67% vs no subheadings: 9/22, 41%), allocation concealment (subheadings: 21/49, 43%; no 
subheadings: 4/22, 18%), blinding (subheadings: 42/49, 86% vs no subheadings: 12/22, 
55%), CONSORT flow diagram (subheadings: 40/49, 82% vs no subheadings: 9/22, 41%), 
baseline information table (subheadings: 37/49, 76%; no subheadings: 11/22, 50%), study 
limitations (subheadings: 42/49, 86%; no subheadings: 8/22, 36%) and generalizability 
(subheadings: 38/49, 78% vs no subheadings: 3/22, 14%) were more commonly adequately 
reported in submissions incorporating subheadings. Notwithstanding this, items such as 
sample size, allocation concealment or estimates/confidence intervals remain in need of a 
considerable improvement in reporting (Table 2). 
For the evaluation of the reporting quality of the submitted RCTs, trials incorporating 
subheadings achieved a score of 15.2 percentage units higher compared to ones without 
(95%CI: 10.5, 20.0; p<0.001). The mean overall score for those trials was 87.3%. Reporting 
quality for each item is also presented in Figure 1 for submissions with or without the use of 
subheadings. Four items are not presented in the forest plot as these were not applicable for 
the majority of the examined RCTs (ie. similarity of interventions, subgroup analyses, if 
binary outcome/absolute numbers, ancillary analyses). 
  
   
Figure 1. Forest plot presenting reporting items for RCTs submitted using subheadings 
compared to RCTs not using subheadings.  
Discussion 
Main Findings 
The impact of CONSORT on trial reporting is established with a previous review alluding to 
improved reporting within 25 of 27 items in CONSORT-endorsing journals[5]. Nevertheless, 
reports documenting inadequate compliance are pervasive throughout the biomedical 
literature, with statistically significant differences between endorsers and non-endorsers 
found in relation to just 4 of 27 items in the afore-mentioned systematic review[5]. It is 
therefore important that the research and operational focus shifts to developing and 
refining approaches to improving adherence with these established guidelines[13]. Ensuring 
compliance with key reporting guidelines is fraught with difficulties including lack of 
awareness among authors, time and resource implications for editorial staff and peer 
reviewers, and lack of knowledge and expertise in relation to guideline implementation 
among editors. The present study outlines a user friendly and simple approach, which 
appears to have been effective in improving the CONSORT compliance of initial submissions 
to a dental specialty journal. 
Limitations and strengths  
This relatively simple approach complements previous efforts within this specialty journal 
involving stepwise editorial involvement and feedback to authors which was previously 
shown to improve CONSORT compliance [9]. The CONSORT checklist remains accessible 
through the journal website and it is possible for authors to use this list. However, access to 
or passive recommendation of use of the checklist alone is not sufficient to ensure optimal 
reporting [9] and its effect will be negated by the requirement for all accepted manuscripts 
to conform to the use of CONSORT-based subheadings. The updated approach is a more 
passive process that requires relatively little editorial input. Specifically, baseline 
interventions included publication of an exemplar trial report on the journal website and a 
specialty-specific CONSORT explanatory document within the journal[11,12]. Thereafter, less 
editorial input is required, however the quality of reporting of CONSORT sub-items is still 
assessed by the editorial team. A potential pitfall of this approach is that adherence to 
templates can result in “filling the blanks” to satisfy formatting requirements. The extent of 
this type of bias is hard to assess; however, it does not appear to be significant.  
The present study involved a relatively small sample of trials; however, the improvement in 
reporting among initial submissions was convincing. Moreover, analysis involved all trial 
submissions over a defined period and we were able to scrutinize initial submissions both for 
trials that went on to be accepted for publication and rejected. A similar approach has been 
used within specific medical journals[14]. As such, it is reasonable to assume that this is a 
representative cross-section of orthodontic clinical trials and to infer that the present 
approach has had a significant positive impact on clinical trial submissions to this specialty 
journal.  
Findings in context  
The overall CONSORT compliance rates among submissions conforming to and not using the 
subheading system in the present cross-sectional survey were 87.3% and 72.1%, 
respectively. These figures compare favourably with previous reports based on passive 
promotion of CONSORT guidance within the biomedical literature with a survey of 105 trials 
published in 29 journals alluding to adequate reporting in over 50% of trials for just 5 of 11 
key methodological factors[8]. Significantly better compliance was found in CONSORT 
promoting journals but reporting was still limited even among these journals with, for 
example, allocation concealment and blinding of the assessor adequately reported in just 
57% and 47%, respectively, of trials published in CONSORT endorsers[8]. A caveat to these 
figures, however, is the inconsistency among endorsing journals in relation to specific 
expectations of clinical trial submissions, with Shamseer et al. (2016) [15] highlighting that 
42% of CONSORT endorsing journals explicitly stating use of CONSORT to be obligatory, 
while 38% require a completed checklist, and 39% also outline explicitly the need for 
inclusion of a flow diagram. When compared to previously published reports of RCTs within 
the same orthodontic journal, the quality of reporting of initial submissions without 
subheadings was similar to published reports after peer review from 2007 to 2009 (overall 
percentage score 62.9%) [16] as well as from 2010 to 2013 (overall percentage score 73.1%) 
[7],  while initial submissions complying with the subheading system outstripped these 
published articles in terms of CONSORT compliance (87.3%; Figure 2). It is not unreasonable 
to assume that following peer-review CONSORT compliance would likely improve 
further[14].  
The present approach was augmented by the use of an exemplar clinical trial published on 
the journal website, which was integral to the process. It was, however, complemented by 
the publication of a specialty specific, orthodontic CONSORT explanatory document, which 
was published in the print journal[9]. The intention of the tailored CONSORT guidance was 
to develop a document which might resonate more with researchers within the specialty as, 
while the original CONSORT document incorporates a range of examples, these may be less 
well understood by researchers from divergent research areas. The effect of this 
undertaking is unclear, although we do believe to have had much less impact than the 
introduction of subheadings. As such, if attempts are made to mimic the present system in 
other journals, the use of a specialty-specific CONSORT is likely dispensable. 
Implications of results  
Based on the present analysis, it is reasonable to assume that the use of subheadings 
resulted in improved CONSORT compliance within initial submissions to a specialty journal 
(AJO-DO). Moreover, the AJO-DO has the highest impact factor of any orthodontic journal 
and it is known that potential authors often target journals based on impact factor 
hierarchy[17,18]. It is possible that articles which are not accepted for publication in this 
journal may subsequently be accepted elsewhere while benefiting from the enhanced 
CONSORT compliance induced by the subheadings format. The benefit of the present 
approach may conceivably, therefore, permeate into other journals within the specialty. 
While the use of CONSORT and other guidelines including PRISMA and to a lesser 
extent STROBE are encouraged by most journals [19,20], this does not necessarily 
translate into enhanced adherence and reporting completeness. Indeed, specifically 
within the area of restorative dentistry, CONSORT was also found to have limited 
impact, leading to a call for more innovative approaches to improving adherence [21].  
The use of subheadings according to CONSORT may be mimicked in other dental journals 
and indeed more widely in medical journals. As such, the present approach has the potential 
for widespread utility. This is particularly important and timely as a realization has emerged 
that adherence to reporting guidelines based on passive approaches is suboptimal almost 
universally[22,23]. Moreover, analogous approaches can be adopted for other study designs 
with AJO-DO, for example, also adopting a similar approach to presentation of systematic 
reviews (SRs) according to PRISMA sub-items. 
The implications of improved trial reporting which may stem from the present or similar 
approaches are clear with the financial and ethical implications of waste in clinical research 
being especially stark[24]. Moreover, the yield from systematic reviews may also be 
hampered by inadequate primary study design and reporting with a recent meta-
epidemiological study within orthodontic SRs highlighting that meta-analysis was possible in 
just 27% of 157 systematic reviews over a 14-year period with a median of just 4 studies 
contributing to those reviews including meta-analyses[25]. However, this problem is not 
confined to the dental literature with 13.5% of all Cochrane SRs which incorporated a GRADE 
assessment shown to have a high level of evidence with the quality of evidence most often 
rated down due to methodological limitations or due to imprecision[26]. Design imitations 
typically related to problems due to inadequate randomization procedures including 
allocation concealment, lack of blinding and large losses to follow-up[26,27]. The pressing 
need to produce high-quality primary research studies throughout the biomedical literature 
and therefore for robust guideline implementation persists. 
CONCLUSIONS  
The adoption of a relatively simple and low cost approach was successful in enhancing 
CONSORT compliance in a specialty dental journal. This method may have wider utility in 
view of the need to supersede passive approaches to implementation of accepted reporting 
guidelines. 
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Figure 2. Mean percentage CONSORT compliance score in the AJO-DO based on the present 
and previous analyses. 7, 15 
 
 
Table 1. List of recommended subheadings based on CONSORT diagrams. 
 
1 Title 
2 Structured abstract 
 Introduction 
3 Background 
4 Specific objectives or hypotheses 
 Methods 
5 Trial design and any changes after trial 
commencement 
6 Participants, eligibility criteria, and settings 
7 Interventions 
8 Outcomes (primary and secondary) and any changes after trial 
commencement 
9 Sample size calculation 
10 Interim analysis and stopping guidelines 
11 Randomization (random number generation, allocation 
concealment, implementation) 
12 Blinding 
13 Statistical analysis (primary and secondary outcomes, subgroup 
analysis) 
 Results 
14 Participant flow (include flow diagram, early stopping and time 
periods) 
15 Baseline data (include baseline table) 
16 Numbers analyzed for each outcome, estimation and precision, 
subgroup analyses 
17 Harms 
 Discussion 
18 Main findings in the context of the existing evidence, 
interpretation 
19 Limitations 
20 Generalizability 
 Registration  
 Protocol 
 Funding 
 
 
Table 2. Frequency distributions on reporting of items based on the CONSORT checklist and 
included in the subheadings, according to the structure of the manuscript at initial 
submission. 
 
   
 Presence of subheadings at submission stage 
 No Yes Total 
  No. % No. % No. % 
Title             
Adequate 6 27 46 94 52 73 
Inadequate 16 73 3 6 19 27 
Structured Abstract             
Adequate 4 18 42 86 46 65 
Inadequate 18 82 7 14 25 35 
Background             
Adequate 19 86 48 98 67 94 
Inadequate 3 14 1 2 4 6 
Introduction             
Adequate 18 82 47 96 65 92 
Inadequate 4 18 2 4 6 8 
Objective             
Adequate 20 91 48 98 68 96 
Inadequate 2 9 1 2 3 4 
Trial Design             
Adequate 11 50 41 84 52 73 
Inadequate 8 36 8 16 16 23 
No description 3 14 0 0 3 4 
Changes after trial commencement             
Adequate 0 0 2 4 2 3 
Non-applicable 21 95 47 96 68 96 
No description 1 5 0 0 1 1 
Eligibility criteria             
Adequate 22 100 49 100 71 100 
Settings             
Adequate 18 82 48 98 66 93 
Inadequate 2 9 1 2 3 4 
No description 2 9 0 0 2 3 
Interventions             
Adequate 22 100 48 98 70 99 
Inadequate 0 0 1 2 1 1 
Outcomes             
Adequate 21 95 47 96 68 96 
Inadequate 1 5 1 2 2 3 
No description 0 0 1 2 1 1 
Outcome changes             
Adequate 0 0 1 2 1 1 
Non-applicable 22 100 48 98 70 99 
Sample Size             
Adequate 6 27 25 51 31 44 
Inadequate 14 64 23 47 37 52 
No description 2 9 1 2 3 4 
Interim analysis             
Adequate 0 0 2 4 2 3 
Non-applicable 22 100 47 96 69 97 
Random number generation             
Adequate 9 41 33 67 42 59 
Inadequate 10 45 16 33 26 37 
No description 3 14 0 0 3 4 
Restrictions in randomization             
Adequate 6 27 13 27 19 27 
Inadequate 0 0 4 8 4 6 
No description 16 73 32 65 48 68 
Allocation Concealment             
Adequate 4 18 21 43 25 35 
Inadequate 6 27 15 31 21 30 
No description 12 55 13 27 25 35 
Implementation of Randomization             
Adequate 8 36 27 55 35 49 
Inadequate 1 5 14 29 15 21 
No description 13 59 8 16 21 30 
Blinding             
Adequate 12 55 42 86 54 76 
Inadequate 2 9 3 6 5 7 
Non-applicable 1 5 2 4 3 4 
No description 7 32 2 4 9 13 
Similarity of Interventions             
Adequate 3 14 6 12 9 13 
Inadequate 1 5 1 2 2 3 
Non-applicable 16 73 40 82 56 79 
No description 2 9 2 4 4 6 
Statistical Methods             
Adequate 13 59 33 67 46 65 
Inadequate 9 41 16 33 25 35 
Subgroup analysis             
Adequate 2 9 2 4 4 6 
Inadequate 1 5 2 4 3 4 
Non-applicable 19 86 44 90 63 89 
No description 0 0 1 2 1 1 
Flow Diagram with reasons             
Adequate 9 41 40 82 49 69 
Inadequate 2 9 9 18 11 15 
No description 11 50 0 0 11 15 
Recruitment Dates             
Adequate 7 32 41 84 48 68 
No description 15 68 8 16 23 32 
Premature trial stop             
Adequate 0 0 1 2 1 1 
Non-applicable 22 100 48 98 70 99 
Baseline Table             
Adequate 11 50 37 76 48 68 
Inadequate 4 18 8 16 12 17 
No description 7 32 4 8 11 15 
Intention-to-treat             
Adequate 2 9 6 12 8 11 
Inadequate 2 9 5 10 7 10 
No description 18 82 38 78 56 79 
Estimates/Confidence Intervals             
Adequate 3 14 10 20 13 18 
Inadequate 0 0 8 16 8 11 
No description 19 86 31 63 50 70 
If Binary Outcome/absolute numbers             
Adequate 1 5 6 12 7 10 
Non-applicable 21 95 43 88 64 90 
Ancillary analysis             
Adequate 0 0 1 2 1 1 
Inadequate 1 5 1 2 2 3 
Non-applicable 21 95 47 96 68 96 
Harms             
Adequate 4 18 32 65 36 51 
Inadequate 3 14 2 4 5 7 
Non-applicable 3 14 12 24 15 21 
  
No description 12 55 3 6 15 21 
Limitations             
Adequate 8 36 42 86 50 70 
Inadequate 3 14 1 2 4 6 
No description 11 50 6 12 17 24 
Generalizability             
Adequate 3 14 38 78 41 58 
Inadequate 3 14 3 6 6 8 
No description 16 73 8 16 24 34 
Interpretation             
Adequate 10 45 43 88 53 75 
Inadequate 11 50 6 12 17 24 
No description 1 5 0 0 1 1 
Registration             
Adequate 5 23 8 16 13 18 
Inadequate 0 0 2 4 2 3 
Non-applicable 5 23 33 67 38 54 
No description 12 55 6 12 18 25 
Protocol             
Adequate 3 14 5 10 8 11 
Inadequate 1 5 2 4 3 4 
Non-applicable 6 27 37 76 43 61 
No description 12 55 5 10 17 24 
Funding             
Adequate 8 36 17 35 25 35 
Non-applicable 5 23 28 57 33 46 
No description 9 41 4 8 13 18 
Total 22 100 49 100 71 100 
